VCAM1 and neoplasm: Treatment of ovarian tumor-bearing mice with anti-α4ß1 antibodies alone had no effect, whilst combined treatment with carboplatin, human-specific α4ß1 blocking antibodies and anti-VCAM-1 antibody significantly reduced the tumor burden [73].